Thank you, Madam Chair.
I want to start with Dr. Salama for two reasons.
One is that you come from my hometown, Edmonton, and we are neighbours in my riding of Edmonton Southeast. The second thing is that you are doing the practical stuff when it comes to industry and making drugs that the public can really use. That's really commendable.
During your testimony, you cried out loud about lack of funding. The funding does go to academia to a certain extent, but when it comes to funding the industry, the pharmaceuticals and the researchers who can produce those drugs that can be made available, you have faced a lot of frustration there.
You told the panel that you have 30-plus years of experience in developing drugs. Can you shed some light on what you have done in reaching out to the federal government for funding on the research side—and not just on the academia side—of drug development, and what kind of results have you had?